Ledger.Open graph →

SEC Form D · filed August 6, 2015

VistaGen Therapeutics, Inc

Offering

$10.0M

Sold

$1.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

South San Francisco, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jerrold D. Dotson · South San Francisco, CAExec H. R. Snodgrass · South San Francisco, CAExec · Director Shawn K. Singh · South San Francisco, CAExec · Director Jon S. Saxe · South San Francisco, CADirector Mark Rose · Chicago, ILExec · Director Mark W. Brooker · Houston, TXDirector Earl Webb · Chicago, ILExec Asia Capital Management, L.P · Grand Cayman, Cayman IslandsExec · Director Underdown J. Brian · South San Francisco, CADirector Ishaan Nerurkar · Berkeley, CADirector Michael Theilmann · Berkeley, CAExec · Director Colton Jang · Berkeley, CAExec Paul G. Roess · Chattanooga, TNExec · Director Underdown J. Brian · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗